The Vanguard Group Discloses Stake in Mural Oncology

The Vanguard Group, Inc. has submitted a Form 8.3 to the Irish Takeover Panel, revealing its stake in Mural Oncology plc. On May 28, 2025, Vanguard reported owning 772,903 ordinary shares, constituting 4.48% of Mural Oncology's relevant securities. This disclosure, in compliance with Rule 8.3 of the Irish Takeover Panel Act, highlights Vanguard's significant position.

The form further details the purchase of 54 additional ordinary shares at a price of $2.62 USD each. No stock-settled derivative transactions or agreements are currently reported. Furthermore, Vanguard confirmed there are no indemnity agreements or informal arrangements related to Mural Oncology securities.

This disclosure is part of standard regulatory practice for companies holding interests in securities exceeding 1%. It offers transparency into Vanguard's investment strategies and its involvement in Mural Oncology.